Neurocrine Biosciences will acquire rare disease drugmaker ⁠Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday, marking the neuroscience-focused drugmaker's expansion into ...

Victoria Coates, Heritage Foundation national security and foreign policy vice president and former Trump administration Deputy National Security Advisor, joins 'Squawk Box' to discuss the latest ...

Oil prices whipsawed in volatile trading at the start of the week. The U.S. West Texas Intermediate for May was last around 0 ...

JPMorgan CEO Jamie Dimon in his annual letter to shareholders noted the country's 250th anniversary and called for a broad ...

Mike O'Rourke, chief market strategist at Jones Trading, discusses whether there will be any market impact from the ...

CNBC's Becky Quick reports on the latest news.

Wedbush's Dan Ives discusses why despite so much nervousness in the market, investors can't lose sight of opportunities to ...

Helima Croft, global head of commodity strategy at RBC Capital Markets, discusses the odds the U.S. and Iran can agree to a ...

Netflix are poised to go higher after the company recently raised its subscription prices, according to Goldman Sachs.

CNBC's Andrew Ross Sorkin reports on the latest news.

Fundstrat's Tom Lee joins 'Squawk Box' to discuss how the Iran war is affecting markets, what to expect if the conflict eases ...

Dan Clifton, head of policy research at Strategas, discusses the latest development in the Iran war and the White House ...